Nanotechnology : Biotechnology, Companies and Institutions

3Dm, Inc.

Benj — Mon, 21 Aug 2006 21:11:02 +0100

Ticker Id

Web url

http://www.puramatrix.com/

Contact Email

contact@puramatrix.com

Short description

Street address

PO Box 425025

Zip or postal code

02142

Telephone

1-877-430-9595

Fax

Foundation date

Ceo, president

Zen Chu

Number of employees

Long description

PuraMatrix is 3DM's patented product line of synthetic self-assembling peptide hydrogels invented at MIT. PuraMatrix is the leading commcial synthetic scaffold for 3D cell culture, cancer biology, drug discovery, tissue engineering, bioproduction, and cell therapy research. PuraMatrix is composed of a simple 16 amino acid peptide monomer 1% weight/volume in tissue culture water, which self-assembles in the presence of salt to form ECM-scale nanofibers, that in turn self-assemble into extremely stable, injectable, biocompatible and biodegradable hydrogels. The gels work by coating surfaces or encapsulating cells, allowing for the proper three dimensional (3-D) culture across most cell types, including cell-based assays for neurite outgrowth, angiogenesis, cell migration, cancer invasion, and hepatocyte toxicity. This reproducible integrin-free scaffold can be customized according to the desired microenvironment to closely model the in vivo milieu along with growth factors, cytokines, integrin sequences, and other bioactive molecules.

Additional Commentaries and remarks

Patents

Abraxis Oncology

Benj — Wed, 16 Aug 2006 18:07:50 +0100

Ticker Id

Web url

http://www.abraxisoncology.com/

Contact Email

Short description

Street address

Zip or postal code

Telephone

1-800-564-0216

Fax

Foundation date

Ceo, president

Number of employees

Long description

Abraxis Oncology was formed with the philosophy that "we will not be bound by current dogma." As it became clear to us that nanotechnology (the science of molecular particles, measured in nanometersbillionths of a meter) would intersect with cellular biology, molecular biology, and medicine, we made the bold commitment that we would make this convergence happen.

The key to next-generation advances is creativity. That means asking the questions that may at first glance appear completely counter-intuitive:

"Should we be working with tumor biology instead of fighting it?"
"Can we turn a drug into a source of food for the tumor?"
"Could tumor blood supply be our access point?"

We have transformed the highly promising concept of protein-bound particle chemotherapeutics into an exciting new patient reality, a next-generation taxane. Through research, innovative science, and creative thinking we are working to redefine the treatment of cancer as we know it.

At Abraxis Oncology, we are employing the best of the best from multiple disciplines. From our national sales force to our marketing team, to our medical department, to support services, and beyond, we are committed to making a difference.

Additional Commentaries and remarks

Patents

Acrongenomics Inc.

Benj — Wed, 30 Aug 2006 16:43:35 +0100

Ticker Id

Web url

http://www.acrongen.com/

Contact Email

info@acrongen.com

Short description

Street address

14 Rue Kleberg

Zip or postal code

CH-1201

Telephone

+41 22 716 5300

Fax

+41 22 716 5319

Foundation date

Ceo, president

Platon Tzouvalis MSc

Number of employees

Long description

As the global population escalates every year, medical providers are constantly seeking technologically advanced products and processes from diagnostics to treatment to monitoring patient diseases. We anticipate the technological changes we will inevitably encounter and strive to play an influential role in advancing medical technologies that will undoubtedly benefit the medical community around the world.

Acrongenomics is confident of its ability to satisfy its shareholders and employees by constantly evaluating its business strategy by collaborating with well-established research institutions and investing in innovative scientific projects, converting them into commercial opportunities.

Additional Commentaries and remarks

Patents

Acrongenomics, Inc.

Benj — Thu, 17 Aug 2006 20:13:46 +0100

Ticker Id

Web url

http://www.acrongen.com/

Contact Email

info@acrongen.com

Short description

Street address

14 Rue Kleberg

Zip or postal code

CH-1201

Telephone

+41 22 716 5300

Fax

+41 22 716 5319

Foundation date

Ceo, president

Number of employees

Long description

Additional Commentaries and remarks

Patents

Actelion Ltd & Actelion Pharmaceuticals Ltd

Benj — Sun, 20 Aug 2006 17:15:26 +0100

Ticker Id

Web url

http://www.actelion.com/

Contact Email

info@actelion.com

Short description

Street address

Gewerbestrasse 16

Zip or postal code

4123

Telephone

+41 61 565 65 65

Fax

+41 61 565 65 00

Foundation date

Ceo, president

Number of employees

Long description

Actelion aims to discover or in-license and develop a steady stream of new products as revenue sources based on first-in-class small molecule compounds. In doing so, Actelion is focusing on innovative treatments for highunmet medical needs, where Actelions new drugs can bring therapeutic advantage to patients and economic benefit for the community at large. Actelion also aims to maximize the value of its products, for example, by seeking additional indications for existing drugs.

Actelion has established an infrastructure to develop, register and market its products in key markets worldwide. By doing so, Actelion is generating sustained profitability and ensuring a growth above industry average. When a product's potential indications could serve a patient population so large that Actelion could not adequately serve it with its own marketing force, the company may seek strategic partnerships with other pharmaceutical or biopharmaceutical companies.

Additional Commentaries and remarks

Patents

Activery Biotech SL ( Activery )

Benj — Sun, 03 Dec 2006 13:24:58 +0000

Ticker Id

Web url

http://www.activery.com/

Contact Email

Short description

Street address

C/Berlin 50

Zip or postal code

08029

Telephone

+34 935 820 152

Fax

+34 935 801 354

Foundation date

Ceo, president

Number of employees

Long description

The basic technology platform of Activery®, is DELOS®, the newest and most promising nanoparticle production method using supercritical fluids (SCF).

Initially patented just as a "method for precipitating finely divided solid particles", further developments based on its unique common denominator led to a significant diversification through two new innovative processes.

• DELOS PLUS for the production of composite materials
• DELOS SUSP for production of nanosuspensions and nanoemulsions

In addition, Activery® possesses extensive capabilities using supercritical fluids with the established PCA process for the production of micro-particles and composite materials.

Additional Commentaries and remarks

Patents

Ademtech SA

Benj — Thu, 31 Aug 2006 13:30:01 +0100

Ticker Id

Web url

http://www.ademtech.com/

Contact Email

Short description

Street address

Parc scientifique Unitec 1, 4 allée du doyen Georges Brus

Zip or postal code

33600

Telephone

+33 (0)557 020 200

Fax

+33 (0)557 020 206

Foundation date

Ceo, president

Number of employees

Long description

The association of complementary skills such as physicochemistry, polymer chemistry, immunology, cellular biology, molecular biology and virology leads to the development of novel nano-objects with unique characteristics.

Ademtech manufactures calibrated particles (CV<20%) of 100 to 500 nm, with high magnetic content (70% of iron oxides) and controlled surface bearing various functionalities – carboxylic acids and amine – and biological activities brought by streptavidine, antibodies or proteins A and G.

These magnetic particles are especially designed for concentration, separation, purification and identification of molecules and specific cells. Besides, they are particularly suitable for integration in microfluidic devices.

Ademtech offers its core expertise to customised coupling services based on the nano particules in order to develop specific purification tools.
For the near future, ADEMTECH is developing some diagnostic and scientific research applications offering a global solution to the costumers including devices and instruments.

Additional Commentaries and remarks

Patents

Adnavance Technologies, Inc.

Benj — Thu, 31 Aug 2006 13:00:21 +0100

Ticker Id

Web url

http://www.adnavance.com/

Contact Email

info@adnavance.com

Short description

Street address

860 - 410, 22nd Street East

Zip or postal code

S7K 5T6

Telephone

(306) 651-1930

Fax

(306) 651-1931

Foundation date

Ceo, president

Number of employees

Long description

Founded on discoveries made at the University of Saskatchewan, Adnavance completed two seed financings and commenced operations in early 2003. The Company’s headquarters and engineering facilities are located in Vancouver, BC and its research laboratories are located in Saskatoon, SK.
M-DNA is a novel form of DNA generated by applying the company’s proprietary method of introducing metal ions along the DNA helix. This hybrid, novel form of DNA provides for the highly efficient conduction/exchange of electrons, enabling improved sensitivity and selectivity for application in molecular diagnostics and the development of biosensors. The conductivity properties of DNA also enable the generation and storage of hydrogen.

Additional Commentaries and remarks

Patents

Advion BioSciences, Inc.

Benj — Wed, 23 Aug 2006 18:34:06 +0100

Ticker Id

Web url

http://www.advion.com/

Contact Email

info@advion.com

Short description

Street address

22 Thornwood Drive

Zip or postal code

14850

Telephone

(607) 266-9162 x 314

Fax

(607) 257-5761

Foundation date

Ceo, president

Number of employees

Long description

Advion BioSciences, Inc. was co-founded in 1993 by Jack Henion, Ph.D., and Thomas Kurz who together have a proven track record and years of experience in technological innovation. Based in Ithaca, NY with a wholly-owned subsidiary in the United Kingdom, the company was originally founded as Advanced BioAnalytical Services, Inc., a leading provider of bioanalytical contract services to the pharmaceutical industry. Spurred by the growing demand for MS and lab-on-a-chip technologies in life-sciences research and drug discovery, we changed our name in March 2001 to reflect our expanded vision and focus, providing bioanalytical services and nanoelectrospray products. We employ more than 130 professionals and operate three laboratories housing 23 mass spectrometers and a 1,250 square-foot clean room facility.

Additional Commentaries and remarks

Patents

Agave BioSystems

Benj — Sat, 04 Aug 2007 12:32:50 +0100

Ticker Id

Web url

http://www.agavebio.com/

Contact Email

Short description

Street address

401 East State Street, Suite 200

Zip or postal code

14850

Telephone

(607) 272-0002

Fax

(607) 272-0089

Foundation date

Ceo, president

Number of employees

Long description

Through our expertise in micro and nanofabrication techniques, much of the work centers on the miniaturization of lab-scale diagnostic and analytical instrumentation. Agave BioSystems is also engaged in a number of research projects where biological components for sensor systems are being tailored to complement ongoing work in the area of nanofabrication. Several of these sensors are being developed to combat biowarfare and bioterrorists agents, but will have broad application in the food, environmental and medical industries. Principal funding for our research and development activities is provided by a number of research contracts from agencies including the Department of Defense, the National Institutes of Health, the Environmental Protection Agency, and NASA.

Agave BioSystems enjoys a close collaborative relationship with Cornell University and many of its research groups. Agave BioSystems has also established a highly sophisticated capability with its facilities in Ithaca, NY, Austin, TX and through business relationships with the New York State Center for Advanced Technology in Biotechnology, the Alliance for NanoMedical Technologies, and the Cornell Nanofabrication Facility. By these means, Agave BioSystems has access to a wide range of microfabrication, molecular biology, and biochemistry materials, equipment and facilities.

Additional Commentaries and remarks

Patents

Albany Molecular Research, Inc.

Benj — Wed, 23 Aug 2006 16:48:57 +0100

Ticker Id

Web url

http://www.albmolecular.com/

Contact Email

info@albmolecular.com

Short description

Street address

21 Corporate Circle, PO Box 15098

Zip or postal code

12212-5098

Telephone

518-464-0279

Fax

518-464-0289

Foundation date

Ceo, president

Number of employees

Long description

Founded in 1991, Albany Molecular Research, Inc. (Nasdaq: AMRI) is a chemistry-based drug discovery and development company, focusing on applications for new small molecule prescription drugs. The company conducts R&D projects and collaborates with many leading pharmaceutical, biotechnology and genomics companies, and is developing new chemistry technology for potential prescription drug applications.

For over a decade, Albany Molecular Research, Inc. has helped pharmaceutical and biotechnology companies accelerate the movement of products through the discovery and development pipeline. From lead discovery and optimization, through process development, and on to cGMP manufacturing -- all with a fanatical devotion to quality, speed, and customer satisfaction.

Additional Commentaries and remarks

Patents

Allrun Nano Science & Technology Co., Ltd

allrun — Wed, 19 Dec 2007 07:28:02 +0000

Ticker Id

Web url

http://www.allrunnano.com

Contact Email

service@allrunnano.com

Short description

Street address

Room 308, Building 2, 500Caobao Rd.Shanghai.China

Zip or postal code

200233

Telephone

+86-021-64759692

Fax

+86-021-64759693

Foundation date

Ceo, president

Zuhan Wang

Number of employees

Long description

Created in 2002, Shanghai Allrun Nano Science & Technology Co., Ltd. is located in Shanghai (China) and initially owing a large know-how in nano science and technology. Our staff consists of top-ranking scientists, doctors abroad, and experienced engineers who are active in nano technology field. As a high-tech company in the emerging field of nano science and technology, Allrun Nano aims at bettering human life through creative nano technology by company's talent researchers and customer-oriented philosophy, and developing products that offer a compelling advantage for our customers and strategic partners. The broad collaboration recourses to universities and institutes make the company pioneer in industrialization of nano technology.
Allrun Nano's technologies consist of distinct nanomaterial manufacturing processes, surface treatment technologies of nanomaterial, and its bio-medical application technologies. Allrun Nano has created an integrated platform of nanomaterial technologies that are designed to deliver nanomaterial solutions for market application.
Since 2002, Allrun Nano has set up a close, stable, strategic relationship with Research Institute of Micro/Nano Science and Technology (RIMNST) in Shanghai Jiao Tong University which covers many research platforms such as nanomaterial, nano bio-medicine, nanofabrication, ect.
Our products:superparamagnetic nanoparticles, superparamagnetic fluid, magnetic devices, nanopowder, nano fuction composites, function fanrics and adjuvant agent. More information please click our webside.

Additional Commentaries and remarks

Patents

Alnis BioSciences, Inc.

Benj — Tue, 22 Aug 2006 21:05:25 +0100

Ticker Id

Web url

http://www.alnis.com/

Contact Email

alnis@alnis.com

Short description

Street address

21 Davis drive, Research Triangle park

Zip or postal code

27709

Telephone

(919) 597 6137

Fax

1997

Foundation date

Ceo, president

Number of employees

Long description

Shortly after its founding in 1997, Alnis was awarded a three year DARPA grant to develop a pathogen countermeasure technology. This grant allowed the company to gain considerable skill in the formulation and fabrication of polymeric nanoparticles.

Alnis is now applying its nanoparticle expertise to creating a platform from which many therapeutics can be rapidly and reliably advanced to commercialization. Alnis is developing drugs which will exhibit several outstanding attributes, including optimized pharmacokinetics and strong, specific binding to intended targets.

In addition to drug discovery, Alnis is also investigating targeted delivery of bioactive entities using its nanoparticle materials. Alnis' nanoparticles are constructed through the engineering of proprietary polymeric materials that are biodegradable, nontoxic, and nonimmunogenic.

Additional Commentaries and remarks

Patents

Ambri Limited

Benj — Tue, 22 Aug 2006 21:03:31 +0100

Ticker Id

Web url

http://www.ambri.com/

Contact Email

Communications@ambri.com

Short description

Street address

126 Greville Street

Zip or postal code

2067

Telephone

+61 2 9422 3000

Fax

+61 2 9422 3013

Foundation date

Ceo, president

Number of employees

Long description

Our vision:

Our vision is to increase shareholder value by building businesses based on our membrane and biosensor technology.

Our values:

At Ambri we have developed a set of values which are the shared principles that help us to achieve our vision. We are guided by our values and they form the basis of our decision making.

Additional Commentaries and remarks

Patents

Amirta Center for Nanosciences

Benj — Wed, 04 Jul 2007 15:27:46 +0100

Ticker Id

Web url

http://www.aimshospital.org/research/centre-for-nanosciences.html

Contact Email

Short description

Street address

Amrita Institute Of medical Science, Elamakara, Kochi-26

Zip or postal code

682026

Telephone

0484-4001167

Fax

0484-2802020

Foundation date

Ceo, president

Number of employees

Long description

The Amrita Nano Biomedical Engineering Centre, or ANBEC, has been established to conduct research and development work on devices and components at the interface between biology, medicine and engineering, where nanoscience and technology can provide a significant value added benefit over existing technologies. The focus of the centre is research for a variety of medical applications in diagnostics and treatment, including:

* Tissue Nanoengineering
* Nanostructured Membranes and Thin Films
* Nanocomposites
* Surface Nanomodification

Additional Commentaries and remarks

Patents

Andor Technology plc

AndorTechnology — Fri, 11 Jan 2008 11:07:21 +0000

Ticker Id

Web url

http://www.andor.com

Contact Email

marketing@andor.com

Short description

Street address

425 Sullivan Avenue

Zip or postal code

06074

Telephone

+44 28 9023 7126

Fax

+44 28 9031 0792

Foundation date

Ceo, president

Conor Walsh

Number of employees

Long description

Andor Technology plc is at the forefront of developing and manufacturing instruments for the global spectroscopy and scientific imaging markets.

The company's range of CCD and intensified CCD camera systems are used throughout the world for academic, industrial and government research across a wide range of fields such as biotechnology, physics and chemistry. Using Andor products these customers can break new ground by performing experiments that were previously considered impossible. Independently conducted customer research confirms that Andor’s low light solutions are considered world beating.

Established in 1989, Andor's Corporate Headquarters are in Belfast, Northern Ireland. Operating in a global market, Andor's US Headquarters opened in Connecticut in 1997. Andor has regional sales offices in Europe and the US. Andor Japan, established in August 2000, handles the company's Asia / Pacific Operations. More recently in December 2006, the company opened its first representative office in Beijing, China.

Andor sells its products globally to academic, research and OEM markets directly, through distributors and value added resellers.

The company successfully listed onto the London Stock Exchange’s AIM market and commenced dealings in its Ordinary Shares in December 2004 (AND).

Additional Commentaries and remarks

Patents

Angstrom Medica, Inc.

Benj — Wed, 23 Aug 2006 18:31:15 +0100

Ticker Id

Web url

http://www.angstrommedica.com/

Contact Email

info@angstrommedica.com

Short description

Street address

150-A New Boston Street

Zip or postal code

01801

Telephone

781.933.6121

Fax

Foundation date

Ceo, president

Number of employees

Long description

Angstrom Medica is a development-stage company founded in June 2001 by Edward Ahn, Ph.D., Sudhir Borgonha M.D. and Darren Obrigkeit Ph.D. Angstrom Medica is a spin-off from the Nanostructured Materials Research Laboratory in the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT).

The company's mission is to develop and commercialize its proprietary nanotechnology to transform the standard of care in areas of medicine where biomaterial technology drives clinical outcomes. Angstrom Medica's technology platform can be applied to a wide range of medical applications, including orthopedic surgery, drug delivery, and cardiovascular medicine. Our initial products will target orthopedic implants for trauma, reconstructive and plastic surgery.

Additional Commentaries and remarks

Patents

ANP Technologies, Inc.

Benj — Wed, 16 Aug 2006 15:13:46 +0100

Ticker Id

Web url

http://www.anptinc.com/

Contact Email

Short description

Street address

824 Interchange Boulevard

Zip or postal code

19711

Telephone

(302) 283-1730

Fax

(302) 283-1733

Foundation date

Ceo, president

Number of employees

Long description

ANP Tech possesses two proven patented technology platforms: (a) nanomanipulation-based biological detection devices, and (b) nanoencapsulation-based protein delivery systems.

Nanomanipulation: Three commercially available products will be fabricated through this technology platform. These include: (i) handheld assays for bio-agent detection, (ii) microarrays for the diagnosis of disease and testing for human exposure to known and unknown pathogens, and (iii) protein-based microarrays for high-throughput discovery of new protein targets and drug leads.

Nanoencapsulation: Our nano-protein delivery system is capable of safely and cost-effectively delivering a variety of proteins through injection, nasal, and inhalation methods. The technology is proven superior to the existing stealth liposome and biodegradable polymer technologies in terms of cost, ease of formulation, long-term protein stability, and blood circulation time.

Additional Commentaries and remarks

Patents

Anvil The Materials Forge Inc.

Wed, 23 May 2007 22:31:11 +0100

Ticker Id

Web url

http://www.has.vcu.edu/che/people/bio/carpenter.html

Contact Email

rebrowndc813@yahoo.com

Short description

Street address

9053 Aldingham Place

Zip or postal code

23116

Telephone

804-244-0134

Fax

Foundation date

Ceo, president

Dr. Everett E. Carpenter

Number of employees

Long description

Additional Commentaries and remarks

Patents

Applied Molecular Evolution, Inc.

Benj — Wed, 23 Aug 2006 18:28:17 +0100

Ticker Id

Web url

http://www.amevolution.com/

Contact Email

Short description

Street address

3520 Dunhill Street

Zip or postal code

92121

Telephone

858.597.4990

Fax

858.597.4950

Foundation date

Ceo, president

Number of employees

Long description

AME's research team applies our proprietary AMEsystem directed evolution protein engineering technology to create improved therapeutic protein candidates. The AMEsystem was designed, developed and continuously upgraded over the last decade by our research team specifically to address the unique challenges of optimizing human biotherapeutics. In the process, AME has also developed an unparalleled record of success in optimizing protein therapeutic candidates.

Directed Evolution is a precise and controlled three-step process to create proteins with optimized functions. In the first step, a library of variant genes is created based on an initial gene that encodes for a protein of interest. In the second step, the variant genes are expressed into functional proteins. In the third step, the proteins are screened, or tested, for improved function.